DailyStocks Stock Article Search

https://www.zacks.com/stock/news/2319627/organogenesis-orgo-reports-q2-loss-tops-revenue-estimates?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_4-2319627 Aug 08, 2024 - Organogenesis (ORGO) delivered earnings and revenue surprises of -550% and 6.33%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock? 0

https://www.zacks.com/stock/news/2319630/honest-hnst-reports-q2-loss-tops-revenue-estimates?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_4-2319630 Aug 08, 2024 - Honest (HNST) delivered earnings and revenue surprises of 20% and 6.19%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock? 0

https://www.zacks.com/stock/news/2319631/lineage-cell-lctx-reports-q2-loss-tops-revenue-estimates?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_4-2319631 Aug 08, 2024 - Lineage Cell (LCTX) delivered earnings and revenue surprises of 25% and 10%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock? 0

https://www.zacks.com/stock/news/2319638/amprius-technologies-ampx-reports-q2-loss-tops-revenue-estimates?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_4-2319638 Aug 08, 2024 - Amprius (AMPX) delivered earnings and revenue surprises of -18.18% and 36.48%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock? 0

https://www.zacks.com/stock/news/2319616/viav-solutions-viav-q4-earnings-and-revenues-top-estimates?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_4-2319616 Aug 08, 2024 - Viav Solutions (VIAV) delivered earnings and revenue surprises of 14.29% and 0.07%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock? 0

https://www.zacks.com/stock/news/2319620/trupanion-trup-reports-q2-loss-tops-revenue-estimates?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_4-2319620 Aug 08, 2024 - Trupanion (TRUP) delivered earnings and revenue surprises of 22.22% and 1.61%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock? 0

https://www.zacks.com/stock/news/2319618/optimizerx-corp-oprx-tops-q2-earnings-estimates?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_4-2319618 Aug 08, 2024 - OptimizeRx (OPRX) delivered earnings and revenue surprises of 128.57% and 8.10%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock? 0

https://www.zacks.com/stock/news/2319621/amn-healthcare-services-amn-q2-earnings-and-revenues-top-estimates?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_4-2319621 Aug 08, 2024 - AMN Healthcare (AMN) delivered earnings and revenue surprises of 30.67% and 0.33%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock? 0

https://www.zacks.com/stock/news/2319622/natera-ntra-reports-q2-loss-tops-revenue-estimates?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_4-2319622 Aug 08, 2024 - Natera (NTRA) delivered earnings and revenue surprises of 56.52% and 21.54%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock? 0

https://www.zacks.com/stock/news/2319623/hyperfine-inc-hypr-reports-q2-loss-tops-revenue-estimates?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_4-2319623 Aug 08, 2024 - Hyperfine (HYPR) delivered earnings and revenue surprises of 0% and 15.45%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock? 0